DOCSLIB.ORG

Volume 79 Some Thyrotropic Agents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Volume 79 Some Thyrotropic Agents WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS VOLUME 79 SOME THYROTROPIC AGENTS 2001 IARC LYON FRANCE WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS Some Thyrotropic Agents VOLUME 79 This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 10–17 October 2000 2001 IARC MONOGRAPHS In 1969, the International Agency for Research on Cancer (IARC) initiated a programme on the evaluation of the carcinogenic risk of chemicals to humans involving the production of critically evaluated monographs on individual chemicals. The programme was subsequently expanded to include evaluations of carcinogenic risks associated with exposures to complex mixtures, life-style factors and biological and physical agents, as well as those in specific occupations. The objective of the programme is to elaborate and publish in the form of monographs critical reviews of data on carcinogenicity for agents to which humans are known to be exposed and on specific exposure situations; to evaluate these data in terms of human risk with the help of international working groups of experts in chemical carcinogenesis and related fields; and to indicate where additional research efforts are needed. The lists of IARC evaluations are regularly updated and are available on Internet: http://monographs.iarc.fr/ This project was supported by Cooperative Agreement 5 UO1 CA33193 awarded by the United States National Cancer Institute, Department of Health and Human Services. Addi- tional support has been provided since 1986 by the European Commission, since 1993 by the United States National Institute of Environmental Health Sciences and since 1995 by the United States Environmental Protection Agency through Cooperative Agreement Assistance CR 824264. ©International Agency for Research on Cancer, 2001 Distributed by IARCPress (Fax: +33 4 72 73 83 02; E-mail: [email protected]) and by the World Health Organization Marketing and Dissemination, 1211 Geneva 27 (Fax: +41 22 791 4857; E-mail: publications@)who.int) Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved. Application for rights of reproduction or translation, in part or in toto, should be made to the International Agency for Research on Cancer. IARC Library Cataloguing in Publication Data Some thyrotropic agents / IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2001 : Lyon, France) (IARC monographs on the evaluation of carcinogenic risks to humans ; 79) 1. Carcinogens – congresses 2. Thyroid Carcinogens – congresses I. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans II. Series ISBN 92 832 1279 7 (NLM Classification: W1) ISSN 1017-1606 PRINTED IN FRANCE CONTENTS NOTE TO THE READER............................................................................................1 LIST OF PARTICIPANTS............................................................................................3 PREAMBLE ................................................................................................................9 Background..............................................................................................................9 Objective and Scope ................................................................................................9 Selection of Topics for Monographs ....................................................................10 Data for Monographs ............................................................................................11 The Working Group ..............................................................................................11 Working Procedures ..............................................................................................11 Exposure Data........................................................................................................12 Studies of Cancer in Humans ................................................................................14 Studies of Cancer in Experimental Animals..........................................................17 Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms ..........................................................................................20 Summary of Data Reported ..................................................................................22 Evaluation ..............................................................................................................23 References..............................................................................................................27 GENERAL REMARKS..............................................................................................33 THE MONOGRAPHS................................................................................................47 Drugs......................................................................................................................49 Anti-thyroid drugs ..........................................................................................51 Methimazole ............................................................................................53 Methylthiouracil ......................................................................................75 Propylthiouracil........................................................................................91 Thiouracil ..............................................................................................127 Sedatives ......................................................................................................143 Doxylamine succinate............................................................................145 Phenobarbital and its sodium salt ..........................................................161 Antifungal agent: Griseofulvin ....................................................................289 Diuretic: Spironolactone ..............................................................................317 –iii– iv IARC MONOGRAPHS VOLUME 79 Antibacterial agents ......................................................................................339 Sulfamethazine and its sodium salt........................................................341 Sulfamethoxazole ..................................................................................361 Pesticides ............................................................................................................379 Amitrole ........................................................................................................381 Chlordane and heptachlor ............................................................................411 Hexachlorobenzene ......................................................................................493 Toxaphene ....................................................................................................569 Food and cosmetics agent: Kojic acid ................................................................605 Hair dye: 2,4-Diaminoanisole and its salts..........................................................619 Industrial chemicals ............................................................................................647 N,N′-Diethylthiourea ....................................................................................649 Ethylenethiourea ..........................................................................................659 Thiourea ........................................................................................................703 SUMMARY OF FINAL EVALUATIONS ..............................................................727 SUPPLEMENTARY CORRIGENDA TO VOLUMES 1−78..................................729 CUMULATIVE INDEX TO THE MONOGRAPHS SERIES ................................731 NOTE TO THE READER The term ‘carcinogenic risk’ in the IARC Monographs series is taken to mean the probability that exposure to an agent will lead to cancer in humans. Inclusion of an agent in the Monographs does not imply that it is a carcinogen, only that the published data have been examined. Equally, the fact that an agent has not yet been evaluated in a monograph does not mean that it is not carcinogenic. The evaluations of carcinogenic risk are made by international working groups of independent scientists and are qualitative in nature. No recommendation is given for regulation or legislation. Anyone who is aware of published data that may alter the evaluation of the carcino- genic risk of an agent to humans is encouraged to make this information available to the Unit of Carcinogen Identification and Evaluation, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France, in order that the agent may be considered for re-evaluation by a future Working Group. Although every effort is made to prepare the monographs as accurately as possible, mistakes may occur. Readers are requested to communicate any errors to the Unit of Carcinogen Identification and Evaluation, so that corrections can be reported in future volumes. –1– IARC WORKING GROUP ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS: SOME THYROTROPIC AGENTS Lyon, 10–17 October 2000 LIST OF
Load more

Recommended publications
  • Start Wave Race Colour Race No. First Name Surname
    To find your name, click 'ctrl' + 'F' and type your surname. If you entered after 20/02/20 you will not appear on this list, an updated version will be put online on or around the 28/02/20. Runners cannot move into an earlier wave, but you are welcome to move back to a later wave. You do NOT need to inform us of your decision to do this. If you have any problems, please get in touch by phoning 01522 699950. COLOUR RACE APPROX TO THE START WAVE NO. START TIME 1 BLUE A 09:10 2 RED A 09:10 3 PINK A 09:15 4 GREEN A 09:20 5 BLUE B 09:32 6 RED B 09:36 7 PINK B 09:40 8 GREEN B 09:44 9 BLUE C 09:48 10 RED C 09:52 11 PINK C 09:56 12 GREEN C 10:00 VIP BLACK Start Wave Race Colour Race No. First name Surname 11 Pink 1889 Rebecca Aarons Any Black 1890 Jakob Abada 2 Red 4 Susannah Abayomi 3 Pink 1891 Yassen Abbas 6 Red 1892 Nick Abbey 10 Red 1823 Hannah Abblitt 10 Red 1893 Clare Abbott 4 Green 1894 Jon Abbott 8 Green 1895 Jonny Abbott 12 Green 11043 Pamela Abbott 6 Red 11044 Rebecca Abbott 11 Pink 1896 Leanne Abbott-Jones 9 Blue 1897 Emilie Abby Any Black 1898 Jennifer Abecina 6 Red 1899 Philip Abel 7 Pink 1900 Jon Abell 10 Red 600 Kirsty Aberdein 6 Red 11045 Andrew Abery Any Black 1901 Erwann ABIVEN 11 Pink 1902 marie joan ablat 8 Green 1903 Teresa Ablewhite 9 Blue 1904 Ahid Abood 6 Red 1905 Alvin Abraham 9 Blue 1906 Deborah Abraham 6 Red 1907 Sophie Abraham 1 Blue 11046 Mitchell Abrams 4 Green 1908 David Abreu 11 Pink 11047 Kathleen Abuda 10 Red 11048 Annalisa Accascina 4 Green 1909 Luis Acedo 10 Red 11049 Vikas Acharya 11 Pink 11050 Catriona Ackermann
    [Show full text]
  • Surnames 198
    Surnames 198 P PACQUIN PAGONE PALCISCO PACUCH PAHACH PALEK PAAHANA PACY PAHEL PALENIK PAAR PADASAK PAHUSZKI PALERMO PAASSARELLI PADDOCK PAHUTSKY PALESCH PABALAN PADELL PAINE PALGUTA PABLIK PADGETT PAINTER PALI PABRAZINSKY PADLO PAIRSON PALILLA PABST PADUNCIC PAISELL PALINA PACCONI PAESANI PAJAK PALINO PACE PAESANO PAJEWSKI PALINSKI PACEK PAFFRATH PAKALA PALKO PACELLI PAGANI PAKOS PALL PACEY PAGANO PALACE PALLO PACHARKA PAGDEN PALADINO PALLONE PACIFIC PAGE PALAGGO PALLOSKY PACILLA PAGLARINI PALAIC PALLOTTINI PACINI PAGLIARINI PALANIK PALLOZZI PACK PAGLIARNI PALANKEY PALM PACKARD PAGLIARO PALANKI PALMA PACKER PAGLIARULO PALAZZONE PALMER PACNUCCI PAGLIASOTTI PALCHESKO PALMERO PACOLT PAGO PALCIC PALMERRI Historical & Genealogical Society of Indiana County 1/21/2013 Surnames 199 PALMIERI PANCIERRA PAOLO PARDUS PALMISANO PANCOAST PAONE PARE PALMISCIANO PANCZAK PAPAKIE PARENTE PALMISCNO PANDAL PAPCIAK PARENTI PALMO PANDULLO PAPE PARETTI PALOMBO PANE PAPIK PARETTO PALONE PANGALLO PAPOVICH PARFITT PALSGROVE PANGBURN PAPPAL PARHAM PALUCH PANGONIS PAPSON PARILLO PALUCHAK PANIALE PAPUGA PARIS PALUDA PANKOVICH PAPURELLO PARISE PALUGA PANKRATZ PARADA PARISEY PALUGNACK PANNACHIA PARANA PARISH PALUMBO PANNEBAKER PARANIC PARISI PALUS PANONE PARAPOT PARISO PALUSKA PANOSKY PARATTO PARIZACK PALYA PANTALL PARCELL PARK PAMPE PANTALONE PARCHINSKY PARKE PANAIA PANTANI PARCHUKE PARKER PANASCI PANTANO PARDEE PARKES PANASKI PANTZER PARDINI PARKHILL PANCHICK PANZY PARDO PARKHURST PANCHIK PAOLINELLIE PARDOE PARKIN Historical & Genealogical Society of Indiana County
    [Show full text]
  • Socialist Planning
    Socialist Planning Socialist planning played an enormous role in the economic and political history of the twentieth century. Beginning in the USSR it spread round the world. It influenced economic institutions and economic policy in countries as varied as Bulgaria, USA, China, Japan, India, Poland and France. How did it work? What were its weaknesses and strengths? What is its legacy for the twenty-first century? Now in its third edition, this textbook is fully updated to cover the findings of the period since the collapse of the USSR. It provides an overview of socialist planning, explains the underlying theory and its limitations, looks at its implementation in various sectors of the economy, and places developments in their historical context. A new chap- ter analyses how planning worked in the defence–industry complex. This book is an ideal text for undergraduate and graduate students taking courses in comparative economic systems and twentieth-century economic history. michael ellman is Emeritus Professor in the Faculty of Economics and Business, University of Amsterdam, Netherlands. He is the author, co- author and editor of numerous books and articles on the Soviet and Russian economies, on transition economics, and on Soviet economic and political history. In 1998, he was awarded the Kondratieff prize for his ‘contributions to the development of the social sciences’. Downloaded from Cambridge Books Online by IP 128.122.253.212 on Sat Jan 10 18:08:28 GMT 2015. http://ebooks.cambridge.org/ebook.jsf?bid=CBO9781139871341 Cambridge Books Online © Cambridge University Press, 2015 Downloaded from Cambridge Books Online by IP 128.122.253.212 on Sat Jan 10 18:08:28 GMT 2015.
    [Show full text]
  • Heretics of China. the Psychology of Mao and Deng
    HERETICS OF CHINA HERETICS OF CHINA THE PSYCHOLOGY OF MAO AND DENG NABIL ALSABAH URN: urn:nbn:de:bvb:473-opus4-445061 DOI: https://doi.org/10.20378/irbo-44506 Copyright © 2019 by Nabil Alsabah Cover design by Katrin Krause Cover illustration by Daiquiri/Shutterstock.com All rights reserved. No part of this book may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without written permission from the author, except for the use of brief quotations in a book review. ISBN: 978-1-69157-995-2 Created with Vellum During his years in power, Mao Zedong initiated three policies which could be described as radical departures from Soviet and Chinese Communist practice: the Hundred Flowers of 1956-1957, the Great Leap Forward 1958-1960, and the Cultural Revolution of 1966-1976. Each was a disaster: the first for the intellectuals, the second for the people, the third for the Party, all three for the country. — RODERICK MACFARQUHAR, THE SECRET SPEECHES OF CHAIRMAN MAO In many ways, [Deng Xiaoping’s] reputation is underestimated: while Soviet President Mikhail Gorbachev oversaw the peaceful end of Soviet communist rule and the dismembering of the Soviet empire, he had wanted to keep the Soviet Union in place and reform it. Instead it fell apart; communism lost power—and Russia endured a decade of instability […]. Perhaps the most influential political titan of the late 20th century, Deng succeeded in guiding China towards his vision where his fellow communist leaders failed. — SIMON SEBAG MONTEFIORE, TITANS OF HISTORY CONTENTS Introduction ix 1.
    [Show full text]
  • WSAVA List of Essential Medicines for Cats and Dogs
    The World Small Animal Veterinary Association (WSAVA) List of Essential Medicines for Cats and Dogs Version 1; January 20th, 2020 Members of the WSAVA Therapeutic Guidelines Group (TGG) Steagall PV, Pelligand L, Page SW, Bourgeois M, Weese S, Manigot G, Dublin D, Ferreira JP, Guardabassi L © 2020 WSAVA All Rights Reserved Contents Background ................................................................................................................................... 2 Definition ...................................................................................................................................... 2 Using the List of Essential Medicines ............................................................................................ 2 Criteria for selection of essential medicines ................................................................................. 3 Anaesthetic, analgesic, sedative and emergency drugs ............................................................... 4 Antimicrobial drugs ....................................................................................................................... 7 Antibacterial and antiprotozoal drugs ....................................................................................... 7 Systemic administration ........................................................................................................ 7 Topical administration ........................................................................................................... 9 Antifungal drugs .....................................................................................................................
    [Show full text]
  • IHS National Pharmacy & Therapeutics Committee National
    IHS National Pharmacy & Therapeutics Committee National Core Formulary; Last Updated: 09/23/2021 **Note: Medications in GREY indicate removed items.** Generic Medication Name Pharmacological Category (up-to-date) Formulary Brief (if Notes / Similar NCF Active? available) Miscellaneous Medications Acetaminophen Analgesic, Miscellaneous Yes Albuterol nebulized solution Beta2 Agonist Yes Albuterol, metered dose inhaler Beta2 Agonist NPTC Meeting Update *Any product* Yes (MDI) (Nov 2017) Alendronate Bisphosphonate Derivative Osteoporosis (2016) Yes Allopurinol Antigout Agent; Xanthine Oxidase Inhibitor Gout (2016) Yes Alogliptin Antidiabetic Agent, Dipeptidyl Peptidase 4 (DPP-4) Inhibitor DPP-IV Inhibitors (2019) Yes Anastrozole Antineoplastic Agent, Aromatase Inhibitor Yes Aspirin Antiplatelet Agent; Nonsteroidal Anti-Inflammatory Drug; Salicylate Yes Azithromycin Antibiotic, Macrolide STIs - PART 1 (2021) Yes Calcium Electrolyte supplement *Any formulation* Yes Carbidopa-Levodopa (immediate Anti-Parkinson Agent; Decarboxylase Inhibitor-Dopamine Precursor Parkinson's Disease Yes release) (2019) Clindamycin, topical ===REMOVED from NCF=== (See Benzoyl Peroxide AND Removed January No Clindamycin, topical combination) 2020 Corticosteroid, intranasal Intranasal Corticosteroid *Any product* Yes Cyanocobalamin (Vitamin B12), Vitamin, Water Soluble Hematologic Supplements Yes oral (2016) Printed on 09/25/2021 Page 1 of 18 National Core Formulary; Last Updated: 09/23/2021 Generic Medication Name Pharmacological Category (up-to-date) Formulary Brief
    [Show full text]
  • British Family Names
    cs 25o/ £22, Cornrll IBniwwitg |fta*g BOUGHT WITH THE INCOME FROM THE SAGE ENDOWMENT FUND THE GIFT OF Hcnrti W~ Sage 1891 A.+.xas.Q7- B^llll^_ DATE DUE ,•-? AUG 1 5 1944 !Hak 1 3 1^46 Dec? '47T Jan 5' 48 ft e Univeral, CS2501 .B23 " v Llb«"y Brit mii!Sm?nS,£& ori8'" and m 3 1924 olin 029 805 771 The original of this book is in the Cornell University Library. There are no known copyright restrictions in the United States on the use of the text. http://www.archive.org/details/cu31924029805771 BRITISH FAMILY NAMES. : BRITISH FAMILY NAMES ftbetr ©riain ano fIDeaning, Lists of Scandinavian, Frisian, Anglo-Saxon, and Norman Names. HENRY BARBER, M.D. (Clerk), "*• AUTHOR OF : ' FURNESS AND CARTMEL NOTES,' THE CISTERCIAN ABBEY OF MAULBRONN,' ( SOME QUEER NAMES,' ' THE SHRINE OF ST. BONIFACE AT FULDA,' 'POPULAR AMUSEMENTS IN GERMANY,' ETC. ' "What's in a name ? —Romeo and yuliet. ' I believe now, there is some secret power and virtue in a name.' Burton's Anatomy ofMelancholy. LONDON ELLIOT STOCK, 62, PATERNOSTER ROW, E.C. 1894. 4136 CONTENTS. Preface - vii Books Consulted - ix Introduction i British Surnames - 3 nicknames 7 clan or tribal names 8 place-names - ii official names 12 trade names 12 christian names 1 foreign names 1 foundling names 1 Lists of Ancient Patronymics : old norse personal names 1 frisian personal and family names 3 names of persons entered in domesday book as HOLDING LANDS temp. KING ED. CONFR. 37 names of tenants in chief in domesday book 5 names of under-tenants of lands at the time of the domesday survey 56 Norman Names 66 Alphabetical List of British Surnames 78 Appendix 233 PREFACE.
    [Show full text]
  • Most-Common-Surnames-Bmd-Registers-16.Pdf
    Most Common Surnames Surnames occurring most often in Scotland's registers of Births, Marriages and Deaths Counting only the surname of the child for births, the surnames of BOTH PARTIES (for example both BRIDE and GROOM) for marriages, and the surname of the deceased for deaths Note: the surnames from these registers may not be representative of the surnames of the population of Scotland as a whole, as (a) they include the surnames of non-residents who were born / married / died here; (b) they exclude the surnames of residents who were born / married / died elsewhere; and (c) some age-groups have very low birth, marriage and death rates; others account for most births, marriages and deaths.ths Registration Year = 2016 Position Surname Number 1 SMITH 2056 2 BROWN 1435 3 WILSON 1354 4 CAMPBELL 1147 5 STEWART 1139 6 THOMSON 1127 7 ROBERTSON 1088 8 ANDERSON 1001 9 MACDONALD 808 10 TAYLOR 782 11 SCOTT 771 12 REID 755 13 MURRAY 754 14 CLARK 734 15 WATSON 642 16 ROSS 629 17 YOUNG 608 18 MITCHELL 601 19 WALKER 589 20= MORRISON 587 20= PATERSON 587 22 GRAHAM 569 23 HAMILTON 541 24 FRASER 529 25 MARTIN 528 26 GRAY 523 27 HENDERSON 522 28 KERR 521 29 MCDONALD 520 30 FERGUSON 513 31 MILLER 511 32 CAMERON 510 33= DAVIDSON 506 33= JOHNSTON 506 35 BELL 483 36 KELLY 478 37 DUNCAN 473 38 HUNTER 450 39 SIMPSON 438 40 MACLEOD 435 41 MACKENZIE 434 42 ALLAN 432 43 GRANT 429 44 WALLACE 401 45 BLACK 399 © Crown Copyright 2017 46 RUSSELL 394 47 JONES 392 48 MACKAY 372 49= MARSHALL 370 49= SUTHERLAND 370 51 WRIGHT 357 52 GIBSON 356 53 BURNS 353 54= KENNEDY 347
    [Show full text]
  • Optimal 131I Therapy of Thyrotoxicosis SNMMI Annual Meeting, 6/26/2018
    Optimal 131I Therapy of Thyrotoxicosis SNMMI Annual Meeting, 6/26/2018 I Love What I do, i.e. Nuclear Medicine … RADIOACTIVE IODINE THERAPY FOR No other relevant disclosures HYERTHYROIDISM Mark Tulchinsky, MD, FACNM, CCD or conflicts of interest Professor of Radiology and Medicine Division of Nuclear Medicine Penn State University Hospital Radioactive Iodine (RAI) Learning Objectives Administration for Graves’ • Treatment Options Disease: Birthplace of • Medications Radiotheranostics • Surgery Saul Hertz, M.D. • 131I Treatment (RAIT) (April 20, 1905 – July 28, 1950) • The first to study RAI in an • Graves’ Disease w/o Orbitopathy animal model of hyperthyroidism • Graves’ Disease with Orbitopathy • March 31st, 1941, at the age of 35 y, administered • Toxic Adenoma the first RAI treatment • Multinodular Toxic Goiter (RAIT) to a patient with Grave’s disease • Intermittent (recurrent) Thyroiditis • The first to use RAI uptake to inform RAIT, i.e. • Amiodarone Thyrotoxicosis radiotheranostic principle Therapeutic Options for Productive Conditions Amenable to RAIT Hyperthyroidism Condition Etiology • Antithyroid Drug therapy (ATDT) Graves’ disease (~80%) TSH-R-Ab stimulation of thyrocyte Symptomatic control with beta blockers Toxic Multinodular Goiter mutation → TSH-R-Ab activation → Toxic Adenoma autonomous function Thioureas, aka Thionamides, Anti- Hashimoto’s Thyroiditis in autoimmune disease - a variety of Thyroid Drugs (ATD’s) productive phase (“Hashi- cell- and antibody-mediated toxicosis”, overlaps Graves’) immune processes Corticosteroids
    [Show full text]
  • Hebron Maple Festival This Weekend RHAM Juniors Hold Fashion Show
    ★ ★ ★ ★ ★ US. POSTAGE PAID POSTAL CUSTOMER GLASTONBURY CITIZEN, INC. LOCAL RIVEREAST PRESORTED STANDARD NewsServing Amston, Andover, Cobalt, East Hampton, Hebron,Bulletin Marlborough, Middle Haddam, Portland, Colchester and Salem Volume 33, Number 51 Published by The Glastonbury Citizen March 13, 2009 Hebron Maple Festival This Weekend by Sarah McCoy The steel buckets hanging from the sides of explained that the ideal syrup-making weather trees can only mean one thing. With spring just features nighttime temperatures in the low 20s, around the corner, the time has come for the with daytime highs in the 40s, with lots of sun 19th annual Hebron Maple Festival. and little to no wind. While this year’s season The festival will be held this year Saturday started off terribly, both sugarers agreed that and Sunday, March 14 and 15, from 10 a.m.-4 the past few weeks have made up for the slow p.m. both days. The affair will feature events start. “This year might prove to be average,” across the town and plenty of food. Palmer said. “That would be a huge achieve- “It’s unique,” Wayne Palmer, owner of ment considering how the season started.” Winding Brook Sugar House and one of the Palmer places taps in over 850 trees. Last coordinators for this year’s festival, said. year, he said, he produced 250 gallons of syrup. “We’re the only town in Connecticut that does “Last year was one of the best in history,” a maple festival and I’ve been told it rivals any- Palmer said. “It was an anomaly but we could thing in Vermont because we’ve kept money get to 200 this year.” out of the equation.” In addition to its use on pancakes and As in years past, there is free admission to waffles, syrup can be used for all different rea- the Maple Festival.
    [Show full text]
  • Drugs Affectin the Autonomic Nervous System
    Fundamentals of Medical Pharmacology Paterson Public Schools Written by Néstor Collazo, Ph.D. Jonathan Hodges, M.D. Tatiana Mikhaelovsky, M.D. for Health and Related Professions (H.A.R.P.) Academy March 2007 Course Description This fourth year course is designed to give students in the Health and Related Professions (H.A.R.P.) Academy a general and coherent explanation of the science of pharmacology in terms of its basic concepts and principles. Students will learn the properties and interactions between chemical agents (drugs) and living organisms for the rational and safe use of drugs in the control, prevention, and therapy of human disease. The emphasis will be on the fundamental concepts as they apply to the actions of most prototype drugs. In order to exemplify important underlying principles, many of the agents in current use will be singled out for fuller discussion. The course will include the following topics: ¾ The History of Pharmacology ¾ Terminology Used in Pharmacology ¾ Drug Action on Living Organisms ¾ Principles of Pharmacokinetics ¾ Dose-Response Relationships ¾ Time-Response Relationships ¾ Human Variability: Factors that will modify effects of drugs on individuals ¾ Effects of Drugs Attributable to Varying Modes of Administration ¾ Drug Toxicity ¾ Pharmacologic Aspects of Drug Abuse and Drug Dependence Pre-requisites Students must have completed successfully the following courses: Biology, Chemistry, Anatomy and Physiology, Algebra I and II Credits: 5 credits Basic Principles of Drug Action Introduction to Pharmacology a. Basic Mechanisms of Drug Actions b. Dose-response relationships c. Drug absorption d. Biotransformation of Drugs e. Pharmacokinetics f. Factors Affecting Drug Distribution g. Drug Allergy and Pharmacogenetics h.
    [Show full text]
  • 2008 Payroll Information
    Health Gross Pension Insurance Life Insurance Additional Pay* Termination Date (longevity Fire LastName FirstName Department Position Title Earnings Benefit Benefit Benefit Medicare Social Security Work Comp See Addendum 1 Police Longevity and add pay pro‐rated) Longevity GRADY SYLVIA BOARDS & COMMIS/BOARDS &P.T. ARTS CENTER COORD (I) 23,524.40 341.10 1,458.51 575.94 MASTERSON DAVID BUILDING MAINT/G P.T. CUSTODIAN (UNION) 15,718.89 1,642.60 60.00 228.79 978.30 404.04 MUMME REX BUILDING MAINT/G BUILDING MAINTENANCE TECHNICIA 65,227.02 6,816.24 5,544.16 88.20 944.53 4,038.69 1,670.61 LAGUNA ANDRZEJ BUILDING MAINT/G P.T. CUSTODIAN (UNION) 11,845.00 171.74 734.49 304.39 ROSS ROBERT BUILDING MAINT/G P.T. CUSTODIAN (UNION) 10,539.87 1,101.45 60.00 153.71 657.19 274.46 GRAFF IRENE BUILDING MAINT/G BUILDING MAINT. CLERK TYPIST 38,952.69 4,070.56 16,920.90 88.20 564.78 2,415.04 1,440.36 VALDIVIA MIGUEL BUILDING MAINT/G P.T. CUSTODIAN (UNION) 12,358.17 1,291.48 60.00 180.07 769.94 312.50 JOHNSON GEORGE BUILDING MAINT/G BUILDING MAINTENANCE TECHNICIA 58,202.53 6,082.13 3,200.26 88.20 842.19 3,601.23 1,486.49 SCHROEDER JOHN BUILDING MAINT/G ASST. BUILDING MAINT. SUPT. 71,061.38 7,425.86 5,544.16 181.44 1,020.94 4,365.43 1,829.12 GARNICA MOISES BUILDING MAINT/G P.T.
    [Show full text]